Add BrightSurf on Google Email

Swiss Nanoscience Institute, University of Basel


A toxin with a useful twist

Scientists discovered a novel way to fuse lipid vesicles without pre-treatment or harsh conditions using the diphtheria toxin's T domain. This breakthrough enables targeted membrane fusion at neutral pH for applications in lab-on-a-chip technologies, biosensors, and synthetic biology.

SourceSwiss Nanoscience Institute, University of Basel·JournalCommunications Chemistry·TypeExperimental study·DateNov 19, 2025

New production process for therapeutic nanovesicles

A team of researchers has developed a highly efficient production method for extracellular vesicles, which can be used as next-generation therapeutics. The new method yields up to 100 times more particles per cell and hour than conventional methods, making it suitable for applications such as cancer treatment and vaccination.

SourceSwiss Nanoscience Institute, University of Basel·JournalCommunications Biology·TypeExperimental study·DateMay 24, 2023